Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 4.05 USD -1.22% Market Closed
Market Cap: 618.9m USD
Have any thoughts about
Mereo Biopharma Group PLC?
Write Note

Wall Street
Price Targets

MREO Price Targets Summary
Mereo Biopharma Group PLC

Wall Street analysts forecast MREO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MREO is 7.34 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

Lowest
Price Target
6.06 USD
50% Upside
Average
Price Target
7.34 USD
81% Upside
Highest
Price Target
8.4 USD
107% Upside

MREO Last Price Targets
Mereo Biopharma Group PLC

The latest public price target was made on Jun 20, 2024 by Joseph Schwartz from Leerink Partners , who expects MREO stock to rise by 98% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Joseph Schwartz
Leerink Partners
8 USD
Upside 98%
4 months ago
Jun 20, 2024
Mereo BioPharma price target raised to $8 from $6 at Leerink
TheFly
Gil Blum
Needham
7 USD
Upside 73%
5 months ago
Jun 12, 2024
Mereo BipPharma Group (MREO) PT Raised to $7 at Needham
StreetInsider
Jack Allen
Robert W. Baird
8 USD
Upside 98%
5 months ago
Jun 12, 2024
Baird Starts Mereo BipPharma Group (MREO) at Outperform
StreetInsider
Gil Blum
Needham
6 USD
Upside 48%
7 months ago
Mar 28, 2024
Mereo BipPharma Group (MREO) PT Raised to $6 at Needham on increased 'launch expectations for setrusumab in OI'
StreetInsider
Joseph Schwartz
Leerink Partners
Price Target 8 USD
Upside/Downside 98%
View Source
Gil Blum
Needham
Price Target 7 USD
Upside/Downside 73%
View Source
Jack Allen
Robert W. Baird
Price Target 8 USD
Upside/Downside 98%
View Source
Gil Blum
Needham
Price Target 6 USD
Upside/Downside 48%
View Source
Mereo Biopharma Group PLC Competitors:
Price Targets
ANAB
AnaptysBio Inc
164% Upside
INCY
Incyte Corp
6% Downside
AVTE
Aerovate Therapeutics Inc
10% Downside
SGMT
Sagimet Biosciences Inc
452% Upside
2616
CStone Pharmaceuticals
41% Upside
300896
Imeik Technology Development Co Ltd
27% Upside
NRIX
Nurix Therapeutics Inc
16% Upside
RYTM
Rhythm Pharmaceuticals Inc
3% Upside

Revenue
Forecast

Revenue Estimate
Mereo Biopharma Group PLC

The compound annual growth rate of Mereo Biopharma Group PLC's revenue for the next 3 years is 90%.

N/A
Past Growth
90%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Mereo Biopharma Group PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Mereo Biopharma Group PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MREO's stock price target?
Price Target
7.34 USD

According to Wall Street analysts, the average 1-year price target for MREO is 7.34 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

What is Mereo Biopharma Group PLC's Revenue forecast?
Projected CAGR
90%

The compound annual growth rate of Mereo Biopharma Group PLC's revenue for the next 3 years is 90%.

Back to Top